CT Scan Compared to CXR and LUS in Pneumonia in the Elderly
Key facts
- Who runs it
- University Hospital, Geneva
- Where
- Switzerland3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 473 people enrolled
- Started
- 17 Jun 2021
- Ended
- 1 Jul 2025
- Type of study
- Interventional, 3 groups
- Treatments tested
- Chest X-Ray (CXR)
- Low-dose CT scan (LDCT)
- Lung ultrasonography (LUS)
- Record updated
- 29 January 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Aged >65 years
- Suspected community-acquired or nursing-home acquired pneumonia consulting to the emergency room with at least one respiratory symptom (new or increasing among: cough, purulent sputum, pleuritic chest pain, dyspnea, respiratory rate >20/min, focal auscultatory findings or oxygen saturation <90% on room air) AND at least one symptom or laboratory finding compatible with an infection (temperature >37.8°C or <36.0°C, C reactive protein (CRP) >10 mg/L, PCT >0.25 µg/L, leukocyte count >10 G/L with >85% neutrophils or band forms)
- Signed informed consent
- In the oldest old (patients aged >80 years), the presence of acute delirium or unexplained acute fall can substitute for the presence of either the respiratory or the infectious symptom
Who cannot take part
- Advanced care planning limiting therapy to comfort care only
- Previous enrollment into the current study
- Known uncontrolled psychiatric disorders
- Immediate admission to the intensive care unit (ICU)
- Pneumonia in the past 3 months
- PCR or antigenic test positive for SARS-CoV-2 in the 3 past weeks
- Transfer from another hospital with a diagnosis of pneumonia
- CXR or thoracic CT scan or US already done during the present episode
- Immediate contrast-enhanced CT scan needed
- Prisoners
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Introduction: Pneumonia is a leading cause of mortality and a common indication for antibiotic in elderly patients. However, its diagnosis is often inaccurate. The investigators aim to compare the diagnostic accuracy, the clinical and cost outcomes and the use of antibiotics associated with three imaging strategies in patients >65 years old with suspected pneumonia in the emergency room (ER): Chest-X ray (CXR, standard of care), low-dose CT scan (LDCT) or lung US (LUS).
Read full original descriptionShow less
Methods and analysis: This is a multicenter randomized superiority clinical trial with three parallel arms. Patients will be allocated in the ER to a diagnostic strategy based on either CXR, LDCT, or LUS. All three imaging modalities will be performed but the results of two of them will be masked during 5 days to the patients, the physicians in charge of the patients and the investigators according to random allocation. The primary objective is to compare the accuracy of LDCT vs CXR- based strategies. As secondary objectives, antibiotics prescription, clinical and cost outcomes will be compared, and the same analyses repeated to compare the LUS and CXR strategies. The reference diagnosis will be established a posteriori by a panel of experts. Based on a previous study, the investigatory expect an improvement of 16% of the accuracy of pneumonia diagnosis using LDCT instead of CXR. Under this assumption, and accounting for 10% of drop out, the enrolment of 495 patients is needed to prove the superiority of LDCT over CRX (alpha error =0.05, beta error=0.10).
Impact of the study: Superiority of the LDCT or LUS strategy over CXR would affect recommendations for the diagnosis of pneumonia in elderly patients. A higher accuracy of one of the strategies may decrease antibiotics overuse and lead to better outcomes and reduced costs.
The 3 groups in the trial
- Chest X-Ray (CXR)Treatment being tested
Only CXR (image and standardized report) will be available to the clinician in charge of the patient (standard of care). LDCT and LUS will be performed but not available (clinician will be blinded to LDCT and LUS).
Treatment: Chest X-Ray (CXR), Low-dose CT scan (LDCT), and Lung ultrasonography (LUS)
- Low-dose CT scan (LDCT)Treatment being tested
Only LDCT (image and standardized report) will be available to the clinician (first intervention arm). CXR and LUS will be performed but not available (clinician will be blinded to CXR and LUS).
Treatment: Chest X-Ray (CXR), Low-dose CT scan (LDCT), and Lung ultrasonography (LUS)
- Lung ultrasonography (LUS)Treatment being tested
Only LUS (image and standardized report) will be available to the clinician (second intervention arm). CXR and LDCT will be performed but not available (clinician will be blinded to CXR and LDCT).
Treatment: Chest X-Ray (CXR), Low-dose CT scan (LDCT), and Lung ultrasonography (LUS)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Low-dose CT Compared to Lung Ultrasonography vs Standard of Care for the Diagnosis of Pneumonia in the Elderly: a Multicentre Randomized Controlled Study
- Publications
- Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study).BMJ open, 2024
- LOw-dose CT Or Lung UltraSonography versus standard of care based-strategies for the diagnosis of pneumonia in the elderly: protocol for a multicentre randomised controlled trial (OCTOPLUS).BMJ open, 2022
- Record updated
- 29 January 2026